The US Hematology-Endocrinology franchise is one of the most rapidly growing businesses across US Commercial Division. The franchise is anchored by 2 recently launched products in HYMPAVZI for Hemophilia A & B and Ngenla for Growth Hormone Deficiency and established in-line portfolio brands in both Hemophilia A and B and is looking to further evolve in rare hematology with our Sickle Cell Portfolio, requiring a cohesive presence and continued demonstration of Pfizer’s commitment to the rare bleeding disorders community. The US Hematology Portfolio Marketing Director will serve a critical role for the US Hematology & Endocrinology franchise by leading key hemophilia initiatives across the Factor business (Benefix & Xyntha) and establishing a strong hemophilia portfolio presence to ensure short and long-term success of the franchise. The Marketing Director will be responsible for leading the hospital & bleed management strategy for the Factor brands & Hemophilia portfolio to include messaging, omnichannel strategy, development of promotional materials and management of agency relationships. The role will support effective portfolio planning and resource allocation across the entire Hemophilia franchise, while also identifying strategic and tactical opportunities to maximize portfolio value across the broader franchise Hematology and Endocrine Franchise. This position requires strong strategic, analytical, execution and decision-making skills. The successful candidate should be a self-starter with proven track record of exceptional leadership and cross-functional collaboration, demonstrating ability to prioritize, high agility and an innovative mindset to support the future vision for the portfolio. This role will lead cross-functional teams to deliver on financial and operational targets, driving strategic and tactical execution across the factor business. This position will report to the US Hematology Portfolio and Factor Lead.